Lynn Morrison

427 total citations
22 papers, 335 citations indexed

About

Lynn Morrison is a scholar working on Surgery, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lynn Morrison has authored 22 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 9 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lynn Morrison's work include Coronary Interventions and Diagnostics (17 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiac Valve Diseases and Treatments (4 papers). Lynn Morrison is often cited by papers focused on Coronary Interventions and Diagnostics (17 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiac Valve Diseases and Treatments (4 papers). Lynn Morrison collaborates with scholars based in Brazil, Belgium and Germany. Lynn Morrison's co-authors include Sara Toyloy, Stefan Verheye, Alexandre Abizaid, Ricardo A. Costa, J. Ribamar Costa, John A. Ormiston, John Yan, Daniel Chamié, Vinayak Bhat and Bryan Lynch and has published in prestigious journals such as Journal of the American College of Cardiology, JACC: Cardiovascular Interventions and Journal of Pediatric Orthopaedics.

In The Last Decade

Lynn Morrison

20 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn Morrison Brazil 6 317 163 135 56 38 22 335
Paweł Gąsior Poland 11 260 0.8× 193 1.2× 99 0.7× 87 1.6× 9 0.2× 58 331
Magdalena Łanocha Poland 11 147 0.5× 198 1.2× 76 0.6× 59 1.1× 79 2.1× 40 288
Yuki Katagiri Netherlands 13 408 1.3× 302 1.9× 156 1.2× 173 3.1× 24 0.6× 43 471
Jim Crowley United States 9 215 0.7× 110 0.7× 187 1.4× 19 0.3× 34 0.9× 17 344
Qingyu Wu China 11 200 0.6× 141 0.9× 176 1.3× 12 0.2× 118 3.1× 39 306
Y. Onuma Netherlands 4 357 1.1× 231 1.4× 138 1.0× 89 1.6× 5 0.1× 5 386
Maxime Formichi France 10 199 0.6× 64 0.4× 233 1.7× 13 0.2× 18 0.5× 20 325
Pasi P. Karjalainen Finland 9 464 1.5× 216 1.3× 60 0.4× 66 1.2× 5 0.1× 38 569
Pier Pasquale Leone Italy 9 159 0.5× 151 0.9× 56 0.4× 70 1.3× 49 1.3× 47 254

Countries citing papers authored by Lynn Morrison

Since Specialization
Citations

This map shows the geographic impact of Lynn Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Morrison more than expected).

Fields of papers citing papers by Lynn Morrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Morrison. The network helps show where Lynn Morrison may publish in the future.

Co-authorship network of co-authors of Lynn Morrison

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Morrison. A scholar is included among the top collaborators of Lynn Morrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Morrison. Lynn Morrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abizaid, Alexandre, Mathias Vrolix, J. Ribamar Costa, et al.. (2017). TCT-330 Multi-Center Evaluation of a Novel 120 μm Novolimus-Eluting, Fully Bioresorbable Coronary Scaffold: First Report of 6-month Imaging and 12-Month Clinical Results. Journal of the American College of Cardiology. 70(18). B135–B136. 2 indexed citations
2.
Verheye, Stefan, Michael Mæng, Carsten Skurk, et al.. (2017). TCT-16 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 5-Year Clinical and Imaging Results. Journal of the American College of Cardiology. 70(18). B7–B8. 1 indexed citations
3.
Nef, Holger, Azeem Latib, Lynn Morrison, et al.. (2017). TCT-331 Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 24-month Results from the DESolve PMCF Study. Journal of the American College of Cardiology. 70(18). B136–B136.
4.
Nef, Holger, Azeem Latib, Lynn Morrison, et al.. (2016). TCT-436 Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 6-month Results from the DESolve PMCF Study. Journal of the American College of Cardiology. 68(18). B176–B176. 3 indexed citations
5.
Verheye, Stefan, Lynn Morrison, Michael Mæng, et al.. (2016). TCT-32 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 4-Year Clinical and Imaging Results. Journal of the American College of Cardiology. 68(18). B13–B13. 4 indexed citations
6.
Verheye, Stefan, Alexandre Abizaid, Roberto Botelho, et al.. (2016). TCT-460 Multi-Center, Randomized Evaluation of the Elixir DESyne® Novolimus Eluting Coronary Stent System with Biodegradable Polymer Compared to a Zotarolimus-Eluting Coronary Stent System: Final 5-Year Results from the EXCELLA BD Study. Journal of the American College of Cardiology. 68(18). B185–B185. 2 indexed citations
7.
Abizaid, Alexandre, Ricardo A. Costa, Joachim Schöfer, et al.. (2016). Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions. JACC: Cardiovascular Interventions. 9(6). 565–574. 88 indexed citations
8.
Verheye, Stefan, Joachim Schöfer, Michael Mæng, et al.. (2015). TCT-17 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 3-Year Clinical and Imaging Results. Journal of the American College of Cardiology. 66(15). B7–B7. 1 indexed citations
9.
Alhaddad, Imad A., Ramiro Trillo, Andrés Íñiguez, et al.. (2015). TCT-575 Multi-Center, Post-marketing Evaluation of the Elixir DESyne® Novolimus Eluting Coronary Stent System: 1-Year Results from the EXCELLA PMCF Study. Journal of the American College of Cardiology. 66(15). B233–B233.
10.
Nef, Holger, Karl-Eugen Hauptmann, Azeem Latib, et al.. (2015). TCT-515 Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 6-month Results from the DESolve PMCF Study. Journal of the American College of Cardiology. 66(15). B210–B210. 1 indexed citations
11.
Abizaid, Alexandre, Michael Mæng, Bernhard Witzenbichler, et al.. (2014). TCT- 610 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results. Journal of the American College of Cardiology. 64(11). B178–B178. 8 indexed citations
12.
Verheye, Stefan, Mark Webster, Jim Stewart, et al.. (2013). CRT-4 Multi-center, First-in-man Evaluation Of The Myolimus-eluting Bioresorbable Coronary Scaffold: 6-month Clinical And Imaging Results. JACC: Cardiovascular Interventions. 6(2). S2–S2. 1 indexed citations
13.
Abizaid, Alexandre, Michael Mæng, Bernhard Witzenbichler, et al.. (2013). TCT-37 Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes. Journal of the American College of Cardiology. 62(18). B13–B13. 3 indexed citations
14.
Costa, Ricardo A., Stefan Verheye, J. Ribamar Costa, et al.. (2013). TCT-419 Side branch patency after implantation of the novel DESolve bioresorbable vascular scaffold system in the treatment of de novo coronary lesions. Journal of the American College of Cardiology. 62(18). B130–B130. 1 indexed citations
15.
Verheye, Stefan, John A. Ormiston, James T. Stewart, et al.. (2013). A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical Evaluation. JACC: Cardiovascular Interventions. 7(1). 89–99. 129 indexed citations
16.
17.
Costa, Ricardo A., Alexandre Abizaid, Mark Webster, et al.. (2012). TCT-39 6-Month Angiographic Follow-up of the Novel DESolveTM Myolimus-Eluting Bioresorbable Coronary Scaffold for the Treatment of Non-Complex Coronary Lesions – Results from the DESolve I First-In-Man Trial. Journal of the American College of Cardiology. 60(17). B12–B12. 1 indexed citations
18.
Costa, J. Ribamar, John A. Ormiston, Alexandre Abizaid, et al.. (2012). TCT-298 Six-month Intravascular Ultrasound Analysis of the DESolve FIM Trial with a Novel PLLA-based Fully Biodegradable Drug-eluting Scaffold. Journal of the American College of Cardiology. 60(17). B85–B85. 3 indexed citations
19.
Verheye, Stefan, Mark Webster, James T. Stewart, et al.. (2012). TCT-563 Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results. Journal of the American College of Cardiology. 60(17). B163–B163. 8 indexed citations
20.
Newman, Christopher J., et al.. (2006). Outcome of Subscapularis Muscle Release for Shoulder Contracture Secondary to Brachial Plexus Palsy at Birth. Journal of Pediatric Orthopaedics. 26(5). 647–651. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paweł Gąsior Breakdown of academic impact, for papers by Magdalena Łanocha Breakdown of academic impact, for papers by Yuki Katagiri Breakdown of academic impact, for papers by Jim Crowley Breakdown of academic impact, for papers by Qingyu Wu Breakdown of academic impact, for papers by Y. Onuma Breakdown of academic impact, for papers by Maxime Formichi Breakdown of academic impact, for papers by Pasi P. Karjalainen Breakdown of academic impact, for papers by Pier Pasquale Leone
Rankless by CCL
2026